Full Press Release Details
Initial Director's Interest
Information or documents not available now must be given
to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/9/2001.
| Name of entity Alterity Therapeutics Limited |
| ABN 37 080 699 065 |
We (the entity) give ASX the following information under
listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Julian Babarczy |
| Date of appointment | 21 November 2025 |
Part 1 - Director's relevant interests in securities
of which the director is the registered holder
In the case of a trust, this includes interests in the
trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within
paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
+ See chapter 19 for defined terms.
Initial Director's Interest Notice
Part 2 - Director's relevant interests
in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the
trust made available by the responsible entity of the trust
| Name of holder & nature of interest | Number & class of Securities |
| Note: Provide details of the circumstances giving rise to the relevant interest. | |
| N/A | Nil |
Part 3 - Director's interests in contracts
Note: In the case of a company, interests which come within
paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
| Detail of contract | N/A |
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| No. and class of securities to which interest relates | N/A |
+ See chapter 19 for defined terms.